RGT001-075

· Regor Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RGT001-075, covering 2025-04-02 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities [Phase 2]